India Supreme Court Sets June 24 Hearing To Consider Anti-Ranbaxy Suit
This article was originally published in PharmAsia News
Executive Summary
India's Supreme Court has scheduled a June 24 hearing to consider a public-interest lawsuit against Ranbaxy Laboratories over its production problems that led to adulterated drugs reaching the market.